male breast cancer
Conditions
Interventions
Male breast cancer group:none
Sponsors
The First Medical Center of Chinese PLA General Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Male patients with pathologically confirmed breast cancer who received initial treatment in our hospital; (2) No neoadjuvant therapy (chemotherapy, endocrine therapy, targeted therapy) received before surgery; (3) Complete clinicopathological and follow-up data available, including age at diagnosis, surgical method, histopathological information (histological grade, pathological stage), molecular pathological information (ER, PR, HER2 status), subsequent adjuvant therapy (chemotherapy, radiotherapy, targeted therapy, endocrine therapy), time of diagnosis, time of recurrence/metastasis, and time of death.
Exclusion criteria
Exclusion criteria: (1) No clear pathological diagnosis, or concurrent presence of other types of cancer; (2) Incomplete clinicopathological data or follow-up data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Tumor recurrence rate;ER/PR expression;HER2 expression; | — |
Countries
China
Contacts
Public ContactXinxin Wang
The First Medical Center of Chinese PLA General Hospital
Outcome results
None listed